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A B S T R A C T
Toxin-antitoxin (TA) systems are ubiquitous in bacteria and on numerous occasions have been postulated to play
a role in virulence of pathogens. Some Staphylococcus aureus strains carry a plasmid, which encodes the highly
toxic PemIKSa TA system involved in maintenance of the plasmid but also implicated in modulation of gene
expression. Here we showed that pemIKSa1-Sp TA system, homologous to the plasmid-encoded PemIKSa, is
present in virtually each chromosome of S. pseudintermedius strain, however exhibits sequence heterogeneity.
This results in two length variants of the PemKSa1-Sp toxin. The shorter (96 aa), C-terminally truncated toxin is
enzymatically inactive, whereas the full length (112 aa) variant is an RNase, though nontoxic to the host cells.
The lack of toxicity of the active PemKSa-Sp2 toxin is explained by increased substrate specificity. The pemISa1-
Sp antitoxin gene seems pseudogenized, however, the whole pemIKSa1-Sp system is transcriptionally active.
When production of N-terminally truncated antitoxins using alternative start codons is assumed, there are five
possible length variants. Here we showed that even substantially truncated antitoxins are able to interact with
PemKSa-Sp2 toxin and inhibit its RNase activity. Moreover, the antitoxins can rescue bacterial cells from toxic
effects of overexpression of plasmid-encoded PemKSa toxin. Collectively, our data indicates that, contrary to the
toxic plasmid-encoded PemIKSa TA system, location of pemIKSa1-Sp in the chromosome of S. pseudintermedius
results in the loss of its toxicity. Interestingly, the retained RNase activity of PemKSa1-Sp2 toxin and func-
tionality of the putative, N-terminally truncated antitoxins suggest the existence of evolutionary pressure for
alleviation/mitigation of the toxin’s toxicity and retention of the inhibitory activity of the antitoxin, respectively.
1. Introduction
Toxin-antitoxin (TA) systems are predominantly associated with
maintenance of genetic material, stress response and persister pheno-
type (Harms et al., 2018; Song and Wood, 2018). TA systems are
widespread in bacteria and found both on plasmids and chromosomes.
Regardless the genomic localisation of TA operons, the antitoxin in-
hibits the deleterious effect of its cognate toxin – either by direct pro-
tein-protein interaction or by blocking toxin synthesis through inter-
ference with its mRNA (Kang et al., 2018). A wide variety of stress
stimuli, such as high temperature, changes of environmental condi-
tions, oxidative damage, nutritional deficiency, bacteriophage infection
or antibiotic treatment can perturb the balance the toxin and antitoxin
level. The resulting activation of the toxin leads to various physiological
effects most often resulting in inhibition of cell growth and division
(Song and Wood, 2020). For the cell, the severity of the consequences
resulting from toxin activation and the reversibility of the effect itself
largely depend on TA operon localisation. For plasmid-encoded TA
systems, the loss of mobile genetic element’s (MGE) encoding at cell
division eliminates daughter cells from the population.
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Cytoplasmatically inherited, inactive TA complex eventually releases
the active toxin which poisons the daughter cell devoid of the TA-en-
coding plasmid. The toxin’s action is irreversible and when prolonged,
leads to dormancy and eventually death. Only cells that inherited the
TA-encoding plasmid are able to grow effectively, which ensures stable
propagation of TA dependent MGEs (Gerdes et al., 1986; Jaffé et al.,
1985). In contrast, chromosome-encoded TA systems cannot be easily
lost at cell division. It has been suggested that chromosomal TA systems
are simply selfish genes (Ramisetty and Santhosh, 2017), but accumu-
lating evidence suggests that such systems have a regulatory function
on the overall cell metabolism (Harms et al., 2018). A fine-tuned me-
chanism of reversible switching between active and inactive state of a
TA system and directed action of a toxin on selected cell components
would constitute prerequisites for such a role. In fact, regulation of
expression of TA system components is facilitated by the genetic or-
ganisation of TA operons, where the antitoxin gene precedes the gene
encoding the toxin, which ensures priority in the production of the
former. More significantly, some antitoxin proteins bind the respective
TA operon promoters and the interaction is modulated by the toxin. The
phenomenon, known as conditional cooperativity, regulates expression
of some TA systems (Overgaard et al., 2008). Regarding the postulated
global regulatory effects of toxins on cell metabolism – the activity of
many toxins is directed against gene transcripts. It is widely debated if
the experimentally demonstrated targeting of only limited number of
cellular transcripts is a random effect or rather reflects a global evo-
lution of cellular transcripts. In either case, the fact is that the overall
protein synthesis is not entirely switched off at the toxin activation and
the activated TA system is able to return to the “dormant” state, which
allows the argument for its regulatory role (Bukowski et al., 2013).
TA systems are currently classified into seven types, according to
the antitoxin nature and the mechanism of action of particular systems
(Song and Wood, 2018). Type II, the most ubiquitous type of TA sys-
tems is of particular relevance to this study. In the type II TA systems
both the toxin and the antitoxin are proteins and the majority of toxins
act as RNases: endoribonuclease (DinJ-YafQ), ribosome-dependent
(YefM-YoeB) or independent mRNase (MqsAR) or mRNA interferase
(MazEF, RelBE, YafNO) (Deter et al., 2017). Type II toxins characterized
to date selectively recognize and target 3–7 bp long RNA sequences
(Masuda and Inouye, 2017). However, within type II TA systems are
also toxins targeting DNA gyrase and cell wall synthesis, CcdB and
PezT, respectively (Mutschler et al., 2011; Van Melderen, 2001).
Staphylococcus pseudintermedius together with S. intermedius and S.
delphini are Gram-positive, coagulase-positive bacteria commonly clas-
sified as Staphylococcus intermedius-group (SIG) (Sasaki et al., 2007).
SIG bacteria are part of normal skin flora, but have also been associated
with variety of infections and diseases. SIG are typically animal pa-
thogens, most commonly isolated from dogs and cats (Pires dos Santos
et al., 2016), however, cases of human infection have also been re-
ported (Magleby et al., 2019; Somayaji et al., 2016; Van Hoovels et al.,
2006). Of further relevance, many S. pseudintermedius strains have ac-
quired multi-drug resistance over the last ten years and are hard to
treat. More importantly, it is postulated that they serve as transfer
vectors of resistance genes to human infecting species. This involves
methicillin-resistant S. pseudintermedius (MRSP), responsible for infec-
tions, some of which are impossible to treat with the currently available
antibiotics (Pires dos Santos et al., 2016).
So far, only a few TA systems have been experimentally character-
ized in Staphylococci. These include yefM/yoeB (Wen et al., 2018;
Yoshizumi et al., 2009), mazEF (Schuster et al., 2013; Zhu et al., 2009)
and related pemIK (Bukowski et al., 2013). An analysis of available
staphylococcal genomes revealed that the mazEF system is present in
practically every examined strain, while pemIK systems are sparse
(∼3% of tested strains) and often located in mobile genetic elements.
Among staphylococcal pemIK systems, one third belonged to pemIK-Sa1
homology group. Contrary to its plasmid-encoded character in other
staphylococci, pemIK-Sa1 was found on chromosomes of SIG species
(Bukowski et al., 2017). The rationale for pemIK-Sa1 system shift onto
the chromosome of SIG species remains unclear.
Here, we analyse the pemIK-Sa1 TA system prevalence in S. pseu-
dintermedius and examine its functionality. Our results prove that the
system is present in virtually all S. pseudintermedius strains, but displays
significant sequence heterogeneity. Despite being an active RNase, the
toxin does not significantly affect the viability of bacterial cells, which
may be explained by its restricted substrate specificity. PemI-Sa1 anti-
toxin encoding genes often seem pseudogenized, however the existence
of N-terminally truncated variants expressed from alternative start co-
dons cannot be excluded, especially for the fact we demonstrate in this
study, which is that such variants retain their ability to bind and inhibit
the toxin when recombinantly expressed.
2. Materials and methods
2.1. Bacterial strains and culture conditions
E. coli strains TOP 10 and BL21(DE3) were used for DNA cloning
and recombinant protein production. S. pseudintermedius strains used in
the study are listed in Supplementary table 3. Strains 235, 244, 21007,
LMG22220 and LMG22221 were used for the analysis of the pemISa1-Sp
and pemKSa1-Sp transcription level. E. coli were cultured in Luria Broth
(LB) while S. pseudintermedius in Tryptic Soy Broth (TSB). Bacteria were
incubated at 37 °C with thorough aeration (180 rpm) for 16 h. For
production of recombinant proteins, the temperature was lowered to 18
°C upon induction with 1 mM IPTG (isopropyl-β-D-thiogalactoside). For
E. coli carrying plasmid constructs derived from pETDuet-1 (Novagen),
pBAD/His B (Thermo Fisher Scientific) and pACYCDuet-1 (Novagen)
media were supplemented respectively with ampicillin (100 μg ml−1)
or chloramphenicol (34 μg ml−1).
2.2. TA genes detection and construction of recombinant plasmids
The putative loci of the toxin-antitoxin operon pemIKSa1-Sp were
amplified from the bacterial chromosome of S. pseudintermedius strains
9, 200, 221, 223, 229, 235, 244, 258kot, 265, 1025, 21007, IKB402,
IKB7616, IKB7824, IKB8470, IKB8512, IKB8686, LMG22219,
LMG22220, LMG22221, using the pemIKpseudUpA-F and
pemIKpseudDown_Rev primers. Amplicons were separated on agarose
gel, purified and sequenced using the above primers. Components of the
toxin-antitoxin system pemIKSa1-Sp (pemISa1-Sp antitoxin; pemKSa1-Sp
toxin) coding for different lengths of the respective proteins were am-
plified from chromosomal DNA of S. pseudintermedius: pemISa1-Sp1 and
pemKSa1-Sp2 from strain LMG22220; pemISa1-Sp2 from strain 235,
pemISa1-Sp3 from strain 21007; pemISa1-Sp4 from strain LMG22221;
pemISa1-Sp5 and pemKSa1-Sp1 from strain 244. Primers used in the study
and obtained plasmid constructs are listed in the Table S1 and Table S2,
respectively. Amplicons were ligated into pTZ-57R/T vector (Thermo
Fisher Scientific) and sequenced. The correctly cloned genes were ex-
cised and inserted into expression vectors: pETDuet™-1, pACYCDuet™-
1, pBAD/His B or pETDuet-AF (Bukowski et al., 2013). QuickChange
site-directed mutagenesis (Stratagene) was used to obtain LY12ED
mutant of pETDuet-PemKSa1-Sp4.
2.3. In vivo co- and cross-interactions of PemIKSa1-Sp system components
In the co- and cross-interaction tests, the co-transformants of E. coli
BL21 (DE3), containing recombinant plasmids pBAD_PemKSa1-Sp2,
pBAD_pemKSa1 (Bukowski et al., 2013) encoding arabinose-induced
toxins and pACYCDuet-PemISa1-Sp, pACYCDuet-pemISa (Bukowski et al.,
2013) coding for IPTG-induced antitoxins were used. Empty pA-
CYCDuet-1 and pBAD/His B were used as a control. The overnight
cultures of co-transformants were diluted 1:100 in LB and grown to
OD600 of 0.1. Then, the bacteria were ten-fold serial diluted (10°, 101,
102, 103, 104 and 105) and plated in a form of dots (2 μL) on 1.5 % agar
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solidified LB medium supplemented with respective antibiotics and
inducer(s): 0.2 % (w/v) L(+)-arabinose (induction of toxin produc-
tion), 0.05 mM IPTG (induction of antitoxin production) or both and
incubated at 37 °C, for 16 h.
2.4. Production and purification of recombinant proteins
Target proteins were overproduced in E. coli BL21(DE3) grown in
TSB medium at 18 °C for 16 h with thorough aeration (180 rpm).
Expression was induced by IPTG (final concentration 1 mM). All ana-
lysed proteins, except of the PemKSa1-Sp1 were isolated from bacteria
by sonication and purified in native conditions by immobilized metal
affinity chromatography (IMAC) on the Ni-NTA resin (Qiagen) and by
Size Exclusion Chromatography (SEC) on the Superdex 75 HR column
(GE Healthcare). PemKSa1-Sp1 toxin was isolated from bacteria by in-
cubation of pellets in a buffer containing 6 M GuHCl and purified in
denaturing conditions by IMAC on Ni-NTA resin. Refolding of this toxin
was optimized using QuickFold™ Protein Refolding Kit (Molecular
Dimensions Ltd.). All purified proteins were homogenous, as de-
termined using SDS-PAGE (Schägger and von Jagow, 1987).
2.5. RNA cleavage by PemK toxins
The analysis was performed according to the modified protocol
described in Zhu et al., 2006, with the exception that the RNA cha-
perone CspA was not included. Briefly, the 0.5 μg of purified PemK
toxin (PemK-Sa1 or PemKSa1-Sp2) was incubated with 1 μg of MS2 RNA
(Sigma Aldrich) in 10 mM Tris pH 8.0 containing 10 mM EGTA, for 30
min, at 37 °C. The cleavage products were analysed by agarose gel
electrophoresis in TAE buffer.
2.6. Analysis of sites of RNA hydrolysis by PemK toxins by primer extension
method
Cleaved MS2 RNA was subjected to primer extension analysis ac-
cording to the modified protocol described in (Nadratowska-
Wesołowska et al., 2010). 0.2 μg of processed RNA was mixed with 1 μL
of 32P-labelled primer (listed in the Table S3) and incubated for 20 min.
at 70 °C. Then slowly cooled to 40 °C and transferred to ice. Next, re-
verse transcriptase buffer (M-MuLV Buffer; Sigma Aldrich), deoxyr-
ibonucleotide triphosphates (dNTPs), reverse transcriptase M-MulV
(Sigma Aldrich) and RNA inhibitors were added. The reaction was
carried out for 60 min at 42 °C and stopped by incubation of the probes
for 5 min at 95 °C. The reaction products were separated by electro-
phoresis in a 7 % polyacrylamide gel, containing 8 M urea. The bands
were autoradiographically visualized and analysed using Quantity One
software (Bio-Rad).
2.7. Assessment of functionality of PemISa1-Sp antitoxins
The in vivo functionality of the PemISa1-Sp antitoxins was analysed,
assessing the ability to rescue the production of PemK-Sa1 recombinant
toxin during a co-expression assay (Bukowski et al., 2013). E. coli
BL21(DE3) were transformed with the pETDuetAF-PemISa1-Sp plasmids
coding for PemK-Sa1 toxin and five analysed variants of PemISa1-Sp
antitoxins (Table S2). The overnight culture was diluted 1:100 in LB
and incubated at an OD600 in the range of 0.6−0.8. IPTG (1 mM) was
added and the culture was continued for 3 h. 1 mL samples were col-
lected every hour and the presence of the target protein(s) was de-
termined by SDS-PAGE and Western Blot, using the Anti-His-tag anti-
bodies.
2.8. In vitro PemIKSa1-Sp complex formation
240 μg of the purified toxin PemKSa1-Sp2, 500 μg of tested antitoxin
PemISa1-Sp or the mixture of both proteins were loaded on the Superdex
75 HR column equilibrated with SEC Buffer (50 mM NaH2PO4 pH 8.0,
100 mM NaCl, 20 % glycerol (v/v)) and resolved with the flow rate of
0.7 mL/min. The peak fractions were analysed by SDS-PAGE and by
cleavage test on RNA MS2.
2.9. Analysis of transcript levels of pemIKSa1-Sp system components
S. pseudintermedius strains LMG22220, 235, 244, 21007, LMG22221
and 244 were cultured in liquid medium TSB. At OD600 of 1 samples (1
mL) were collected by centrifugation and bacterial pellet was sus-
pended in 1 mL of TRI Reagent (Sigma Aldrich). Bacteria were me-
chanically disintegrated using glass beads and Precellys equipment
(Bertin Instruments). Then, 200 μL of chloroform was added to the
obtained cell lysate and the samples were vigorously shaken for 20 s,
and subsequently centrifuged (15,000 rcf, 10 min, 22 °C). The upper
aqueous phase was collected and further processed using GeneJet
Purification Kit (Thermo Fisher Scientific) according to the manu-
facturer’s protocol. Residual DNA was removed with On-Column DNase
I Digestion Set (Sigma Aldrich). Complementary DNA was obtained for
isolated RNA in the reverse transcription reaction using the Maxima H
minus reverse transcriptase (Thermo Fisher Scientific) and random
hexamers. cDNA and primers specific for analysed genes (Table S1)
were used in Real-Time PCR reaction. The level of genes’ transcription
was determined relative to expression of DNA gyrase subunit B.
3. Results
3.1. Chromosomal toxin-antitoxin system pemIKSa1-Sp is widespread
among strains of S. pseudintermedius and widely heterogeneous
Our earlier report on the discovery of PemIKSa TA systems encoded
on S. aureus plasmids argued their regulatory role, despite the location
on mobile genetic elements (Bukowski et al., 2013). Using bioinfor-
matic analysis of a limited number of staphylococcal genomes available
at the time, we identified the presence of homologous systems located
on bacterial chromosomes of staphylococcal species other than S.
aureus. We found variants of the PemIK system in all four analysed
genomes of S. pseudintermedius, however the limited genomic data at
the time did not allow us to conclude the system prevalence, func-
tionality or heterogeneity. In this report we screened our collection of
twenty S. pseudintermedius strains for pemIK operons. Using pe-
mIKpseudUpA-F and pemIKpseudDown_Rev primers (Table S1) we
amplified putative loci. The amplicons were detected by DNA electro-
phoresis for all analysed strains, however differed slightly in size. Thus,
we sequenced the amplified DNA and analysed the obtained sequences
for the presence of open reading frames (ORF) homologous to pemIKSa
genes. Quite surprisingly, we detected significant heterogeneity within
amplicon sequences involving 2 length variants of PemKSa1-Sp toxin
and 5 length variants of PemISa1-Sp antitoxin (Figs. 1, S1 and S2). The
short (96 aa) toxin variant resulted from two-nucleotide insertion in the
vicinity of 3′ end of pemK gene, generating a frame shift and conse-
quently a premature stop codon. The long variant of the toxin
(PemKSa1-Sp2; 112 aa) corresponds to the prototype PemK-Sa1 toxin
from S. aureus. The extent of sequence similarity of PemK toxins form S.
pseudintermedius and S. aureus is variable through the protein and
lowest in the C-terminal region. The accumulation of single-nucleotide
insertions/deletions and substitutions in antitoxin encoding genes
produces a more complicated picture with frame shifts and stop codons
located at the very beginning of the putative PemI coding sequences
suggesting pseudogenisation. However, pseudogenisation of the anti-
toxin gene in the presence of a functional toxin gene would imply
constitutive toxin activity. Thus, we hypothesized that alternative start
codons may be used to express N-terminally truncated antitoxins. In
this scenario, five putative antitoxin variants, PemISa1-Sp1-5, consisting
of 26, 30, 31, 40 and 59 amino acids, respectively, could be expressed
in different strains (Fig. 1A).
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To verify the conclusions of our amplicon analysis we searched the
whole genome sequencing data available for S. pseudintermedius.
Indeed, PemIKSa1-Sp operon was identified in 222 out of 223 analysed
genomes demonstrating its wide penetrance. In each case, the TA
system was located in the same genetic context between genes coding
for putative membrane protein and hemoprotein HemQ. Moreover, in a
vicinity of pemIKSa1-Sp we did not identified transposons or known in-
sertion elements (Fig. 1B). Again, two length variants of the PemKSa1-Sp
toxin were observed, with the long variant PemKSa1-Sp2 (112 aa) being
by far more prevalent (214 hits). The shorter variant (PemKSa1-Sp1, 96
aa) was present only in less than 4% (8 hits) of analysed genomes.
Among antitoxins, the most prevalent variants were PemISa1-Sp4 and
PemISa1-Sp5 (151 and 44 hits, respectively). The “full length” antitoxin
consisting of 89 aa (similar to prototype PemISa from S. aureus plasmid)
was identified only in 5 S. pseudintermedius genomes (Suppl. data set 1).
3.2. The pemIKSa1-SpTA system is transcriptionally active
TA systems often autoregulate their own expression through anti-
toxin and/or toxin-antitoxin complex interaction with the promoter
(Garcia-Pino et al., 2010). Degeneration of pemIKSa1-Sp operons and
possible pseudogenisation of antitoxin genes put into question the
transcriptional activity and functionality of the whole system. To
evaluate this, we isolated RNA from S. pseudintermedius strains
(LMG22220, 235, 244, 21007, LMG22221 and 244), exemplifying each
of the identified variants of pemISa1-Sp and pemKSa1-Sp genes, and
analysed the level of respective transcripts by qRT-PCR. Transcripts
encoding each tested variant were detected in relevant strains (Fig. S3),
which potentially allows for their expression at the protein level. The
level of transcription of all pemISa1-Sp antitoxins was higher than their
corresponding pemKSa1-Sp toxins despite expression of both genes from
a single promoter (one operon). It likely suggests premature tran-
scription termination, possibly induced by hairpin structures in toxin
encoding fragment (Fig. S1). Strain 235 was characterized by an overall
lower relative level of expression of pemIK components, probably as a
result of a point mutation in the putative promoter region (Fig. S1).
3.3. The PemKSa1-Sp1 toxin is non-toxic and its natural C-terminal
truncation abolishes RNase activity
Frameshifts and truncations within pemIKSa1-Sp operon (Fig. S1)
may indicate its translational incompetence (pseudogenization) despite
the transcriptional activity. Lack of relevant antibodies has prevented
us from direct verification of system component expression. However,
the results of a set of indirect experiments presented below argue the
functionality of major identified variants of PemKSa1-Sp toxins and
PemISa1-Sp antitoxins in vivo.
Coding sequences of pemKSa1-Sp1 (96 aa) from strain 244 and
pemKSa1-Sp2 (112 aa) from strain LMG22220 were cloned into an ara-
binose-inducible expression vector pBAD/His B. E. coli were trans-
formed with recombinant plasmids and plated in serial dilutions as dots
on a solid medium containing L(+)-arabinose. Expectedly, the positive
control bacteria transformed with pBAD-PemKSa1 plasmid encoding
PemK toxin from S. aureus CH91 were significantly inhibited in the
presence of the inducer compared to the negative control bacteria
carrying an empty plasmid. Surprisingly, we did not observe growth
inhibition of E. coli carrying pBAD-PemKSa1-Sp1 or pBAD-PemKSa1-Sp2
plasmids (Fig. 2D). This result indicates that despite the high level of
sequence identity (82.2 % for PemKSa1-Sp1 and 80.9 % for PemKSa1-
Sp2) to PemKSa1 toxin from S. aureus, the S. pseudintermedius derived
toxins are not toxic to E. coli.
E. coli is routinely used to verify the functionality of putative TA
systems where the toxin overexpression in the absence of relevant an-
titoxin results in an observable growth defect which is rescued by
concomitant overexpression of the antitoxin (Kato et al., 2019). How-
ever, this model fails in case of PemKSa1-Sp2 which shows no toxic ef-
fect even in the absence of antitoxin – likely because of very limited
substrate specificity. It may not be excluded, nonetheless, that PemKSa1-
Sp2 has a different effect in host cells, which are phylogenetically dis-
tant from E. coli. To test such possibility, a cadmium-inducible pCN51-
PemKSa1-Sp2 plasmid expressing enzymatically active PemKSa1-Sp2 was
transformed to S. pseudintermedius strain LMG22221. Growth inhibition
was not observed upon stimulation of the transgene production with
cadmium when compared to an empty plasmid control (Fig. S5). This
demonstrates that PemKSa1-Sp2 is non-toxic to the native host even in
Fig. 1. Sequence variants of PemIKSa1-Sp toxin-antitoxin system components identified in the analysed pool of S. pseudintermedius chromosomes. (A) Comparison of
the amino acid sequences of antitoxins (PemISa1-Sp; panel A) and toxins (PemKSa1-Sp; panel B), with reference to prototypical plasmid-encoded PemIKSa, reveals two
and five length variants of the toxin and antitoxin, respectively. PemISa1-Sp antitoxins and PemKSa1-Sp1 toxin are respectively N- and C-terminally truncated
compared to S. aureus prototypes. (B) Localization of pemIKSa1-Sp toxin-antitoxin system within chromosome of S. pseudintermedius (based on strain HKU10-03). spl,
serine protease like endopeptidases; tf, putative transcription factor; ars, genes likely involved in arsenic resistance; mem, putative membrane protein; pemIK, toxin-
antitoxin system pemIKSa1-Sp; hemQ, hemoprotein HemQ; pta, phosphotransacetylase; lplA, lipoate-protein ligase A; mdr, multidrug resistance efflux pump; rimL,
acetyltransferase.
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the absence of the antitoxin.
We hypothesized that the difference in toxicity between PemK
toxins derived from S. aureus and S. pseudintermedius resulted from the
lack of RNase activity of the latter toxins. To verify this assumption, we
recombinantly expressed N-terminally His-tagged S. pseudintermedius
toxin variants obtaining efficient overproduction in E. coli BL21(DE3).
Recombinant proteins were purified using chromatographic techniques
(Fig. 2A and B). PemKSa1-Sp1 was obtained from the insoluble fraction
and refolded. PemKSa1-Sp2 was recovered from the soluble fraction.
Toxins were contacted with MS2 RNA and the substrate integrity was
subsequently analysed by agarose gel electrophoresis. Degradation
products were not observed upon incubation of MS2 RNA with
PemKSa1-Sp1, suggesting the protein does not exhibit RNase activity.
On contrary, PemKSa1-Sp2 exhibited RNase activity while the banded
pattern of the product indicated a certain degree of substrate specificity
(Fig. 2C). Seven sites of hydrolysis were identified by primer extension
method (Nadratowska-Wesołowska et al., 2010) and the sites were
identical to those previously identified for PemK-Sa1 from S. aureus
(Bukowski et al., 2013). However, contrary to PemK-Sa1 where all the
U’AUU sites are utilized with equal efficiency, PemKSa1-Sp2 strongly
preferred a single site (CU’AUUU), recognized three additional sites
with relatively high efficiency, while it almost completely excluded
three remaining sites (Fig. S4). Such result suggests that the specificity
of PemKSa1-Sp2 encompasses the four-nucleotide specificity determined
for PemK-Sa1, but also extends beyond this sequence which was not the
case for S. aureus toxin.
3.4. Natural N-terminally truncated PemISa1-Sp antitoxin variants retain
inhibitory activity
All 5 variants of PemI antitoxins in S. pseudintermedius identified in
this study contain substantial N-terminal truncations relative to the
canonical PemISa (88 aa) from S. aureus. To verify if these antitoxins
are still capable of toxin inhibition, a classical coexpression assay (Kato
et al., 2019) was utilized. The coding sequences of pemISa1-Sp antitoxin
variants (Sp1-5, respectively form strains LMG22220, 235, 21007,
LMG22221 and 244) were cloned into expression vector pACYCDuet-1
under control of IPTG-inducible T7 promoter. E. coli BL21(DE3) were
co-transformed with plasmids pACYCDuet-PemISa1-Sp1-5 and arabinose
inducible pBAD-pemKSa1 plasmid expressing PemK-Sa1 (Bukowski
et al., 2013), and plated on solid medium containing proper inducers.
PemK-Sa1 toxin from S. aureus CH91 was used instead of PemKSa1-Sp
for the lack of observable toxic effect of the latter (see above). Ex-
pectedly, the growth of all transformants was inhibited exclusively on
plates containing arabinose while no effect was seen on plates con-
taining only IPTG. PemISa1-Sp2, PemISa1-Sp3 and PemISa1-Sp5 sustained
bacterial growth in the presence of both inducers indicating functional
inhibition of PemK-Sa1 toxin in vivo. PemISa1-Sp1 and PemISa1-Sp4 were
ineffective in alleviating the toxic effects of PemK-Sa1 (Fig. 3B).
Another model, which allows for the evaluation of antitoxin func-
tionality, relies on the observation that efficient overexpression of
PemK-Sa1 toxin in E. coli is possible only when the antitoxin is con-
comitantly supplied (Bukowski et al., 2013). To further evaluate the
activity of Sp1-5 antitoxin variants, a set of recombinant plasmids was
prepared based on pETDuet-AF expressing a functional PemIK-Sa1 TA
system (Bukowski et al., 2013), in which the PemI-Sa1 antitoxin coding
sequence was replaced with sequences encoding the tested S.
Fig. 2. PemKSa1-Sp toxins and their activity in vitro and in vivo. (A.) Production of 6xHis-tagged PemKSa1-Sp toxins in E. coli BL21(DE3). Expression of tested toxin was
induced by IPTG from the following vectors: pETDuet-PemKSa1-Sp1-His (for PemKSa1-Sp1;*) and pETDuet-PemKSa1-Sp2-His (for PemKSa1-Sp2;**; Table S2); and was
monitored by SDS-PAGE. (B.) The purification of the PemKSa1-Sp toxins. PemKSa1-Sp1 was purified by Ni-NTA affinity chromatography (IMAC) in denaturing
conditions and subjected to refolding, whereas the PemKSa1-Sp2 by IMAC, in native conditions, and Size Exclusion Chromatography (SEC). Purity of the obtained
preparations were verified by SDS-PAGE. (C.) Endoribonucleolytic activity of tested PemKSa1-Sp toxins towards RNA from MS2 phage. The PemKSa1-Sp2 toxin
shows endoribonucleolytic activity, while the C-terminally truncated PemKSa1-Sp1 is inactive. 0, the negative control. (D.) Analysis of toxicity of PemKSa1-Sp
toxins toward E. coli cells. Serially diluted (10°-105) E. coli BL21(DE3) cells (at OD600 equal 0.2), transformed with and pBAD/His B (empty), pBADPemKSa1-Sp1 or
pBAD-PemKSa1-Sp2 vectors were spotted on solid medium LBA (upper panel) or LBA supplemented with inducer (0.2 % L(+)-arabinose; lower panel). Contrary to S.
aureus PemK-Sa, the S. pseudintermedius PemKSa1-Sp toxins were not toxic for E. coli, as evidenced by the lack of inhibition of bacterial growth on the medium
supplemented with the inducer.
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pseudintermedius antitoxin variants. E. coli were transformed with the
resulting plasmids and the presence of histidine-tagged PemK-Sa1 was
monitored by SDS-PAGE and Western Blot upon IPTG induction of co-
expression (Fig. 3A). Efficient expression of PemK-Sa1 toxin was sup-
ported only by Sp2, Sp3 and Sp5 variants of PemI-Sp antitoxin, which
corresponds with the results of in vivo protection assay, indicating the
functionality of Sp2, Sp3 and Sp5 variants. Expression of PemK-Sa1 was
significantly compromised when Sp4 was used and detectable only by
Western blot with Sp1 variant. Additionally, the growth rate of bacteria
carrying the plasmids encoding PemKSa1/PemISa1-Sp1 and PemKSa1/
PemISa1-Sp4 was compromised compared to the other tested variants,
either in the presence or absence of IPTG (the latter likely reflecting
promoter leakage). These results indicate only limited functionality of
Sp1 and Sp4 variants.
The above antitoxin functionality tests relied on inhibition of S.
aureus toxin by tested S. pseudintermedius antitoxins. To test the pre-
sumed activity of Sp2, Sp3 and Sp5 against the cognate toxin, we
evaluated the capability of complex formation between PemKSa1-Sp2
toxin and corresponding PemISa1-Sp antitoxin variants by gel filtration.
In parallel, the ability of tested antitoxin variants to inhibit the RNase
activity of the toxin in in vitro assays was evaluated. Gel filtration ex-
periments followed by SDS-PAGE inspection of the elution fractions
demonstrated complex formation between His-tagged PemKSa1-Sp2
toxin and His-tagged PemISa1-Sp antitoxins variants 2, 3 and 5 (Fig. 4,
panels A and B). Moreover, variants 2, 3 and 5 protected MS2 RNA from
degradation by PemKSa1-Sp2 (Fig. 4, panels C). These results indicate
that antitoxin variants Sp2, Sp3 and Sp5 are, indeed, capable of in-
hibiting the cognate toxin.
Our data demonstrate that the activity of the PemI-Sp antitoxin
variants is unrelated to the extent of N-terminal truncation. Highly
truncated variants Sp2 and Sp3 retained their activity, whereas longer
variant Sp4 was inactive. The detailed sequence analysis provided hints
into the differences in antitoxin variant activity. Sp4 sequence differs
from the other antitoxin variants at the N-terminus (contains LY in
place of ED; Fig. 1A). Introduction of LY62ED substitution into pET-
Duet-AF-PemISa1-Sp4 plasmid rescued the coexpression of PemKSa1
toxin to a certain extent (Fig. S6), demonstrating that indeed the sub-
stitution of acidic residues (ED) with uncharged ones (LY) in Sp4 is
responsible for highly reduced activity of Sp4.
4. Discussion
Toxin-antitoxin systems are intriguingly widespread in bacterial
genomes. TA systems were identified both in the chromosomal DNA
and mobile genetic elements such as plasmids (Bukowski et al., 2017,
2013; Zhu et al., 2006). A rapidly growing number of genomic se-
quences revealed that particular TA systems may be found in phylo-
genetically distant bacteria and in different regions of the genome in
related species, which suggests their mobile character (Bukowski et al.,
2017). The driving force of such mobility and its potential con-
sequences for physiology of bacteria remain elusive. Another poorly
explained aspect concerns the prevalence of TA systems, which ranges
from a single strain to a wide occurrence of a particular system among
diverse strains and species. MazEF system is located exclusively on the
chromosome of all staphylococcal strains tested and co-evolves with the
bacteria. Such co-evolution argues for an important physiological role
in staphylococci (Bukowski et al., 2017). Indeed, the system is clustered
in an operon with sigB locus. SigB encodes the alternative sigma factor
Fig. 3. Functionality of the PemISa1-Sp antitoxins. (A) Co-production test. PemKSa1 toxin was co-expressed with tested variants of PemISa1-Sp antitoxins in E. coli.
Lysates before (lane 1) and three subsequent hours after induction with IPTG (lanes 2-4) were separated by SDS-PAGE (upper panel) and the 6xHis-tagged PemKSa1
toxin was identified by Western Blot (lower panel) using anti-His-tag antibodies. PemISa1-Sp2, PemISa1-Sp3, PemISa1-Sp4 and PemISa1-Sp5 rescued the production of
PemKSa1 toxin (*) as observed by SDS-PAGE. PemISa1-Sp1 had little protective effect and PemKSa1 toxin production was discernible only on Western Blot. M-
molecular mass standards. (B) Toxicity protection assay. The serial dilutions of E. coli co-transformed with pBAD-PemKSa1 and one of the following plasmids:
pACYCDuet™-1 (empty), pACYCDuet-PemISa1-Sp1-His, pACYCDuet-PemISa1-Sp2-His, pACYCDuet-PemISa1-Sp3-His, pACYCDuet-PemISa1-Sp4-His or pACYCDuet-
PemISa1-Sp5-His, were spotted on solid medium supplemented with the inducers: IPTG and L(+)-arabinose for induction of antitoxins and toxin expression, re-
spectively. Growth inhibitory effect of PemKSa1 was abolished only by co-expression of PemISa1-Sp2, PemISa1-Sp3, PemISa1-Sp5 antitoxins, but not PemISa1-Sp1 and
PemISa1-Sp4 variants.
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and stress regulator σB of significant importance in staphylococcal
physiology. Importantly, mazEF promoter is needed for full activity of
σB (Donegan and Cheung, 2009). Moreover, in S. aureus MazF toxin was
shown to be able to affect transcripts of virulence factors and thus
modulate the pathogenic potential (Schuster et al., 2015; Zhu et al.,
2009). Interestingly, in non-pathogenic S. equorum, MazF toxin targets
important metabolic and regulatory gene transcripts (Schuster et al.,
2013) despite having exactly the same substrate specificity as S. aureus
homologue. The above facts suggest that it is the genomes that co-
evolve with the toxin and not the other way round.
Prior data suggested that the prevalence/penetrance of PemIK-Sa1
system in staphylococcal genomes was low (up to 1%). The system was
found mostly on plasmids. Among rare cases of the chromosomal
PemIK-Sa1, its localization within the genome varied considerably
(Bukowski et al., 2017). In this work we show that PemIKSa1-Sp has
high penetrance in S. pseudintermedius chromosomes while being
characterized by significant sequence heterogeneity. This heterogeneity
and especially truncations resulted in prior underestimation of the
system penetrance in analyses relying on full-length PemI-Sa1 queries
(Bukowski et al., 2017). In all examined S. pseudintermedius strains,
pemIKSa1-Sp is found in the same genetic context, which suggests that
the system emerged (or was acquired) in one genetic event, presumably
in the distant past, however we did not identified any genetic hallmarks
explaining mechanism of its emergence.
Both components of type II TA systems are proteins. It follows that a
functional system requires transcription and translation of respective
genes. Using qRT-PCR we have demonstrated that pemIKSa1-Sp is tran-
scriptionally active. This seemingly contrasted with the finding of sig-
nificant truncations in antitoxin genes, which had suggested pseudo-
genization. Additionally, recent findings in other systems demonstrated
toxin inactivation by promoter mutations when antitoxins were non-
functional or absent (Fernandez-Garcia et al., 2019). Pseudogenization
of the antitoxin would result in the production of only the toxin that
should poison the cell, or at least arrest its growth, neither of which did
we observe in S. pseudintermedius. Possible explanations are that either
the toxin is not toxic itself or truncated antitoxins are still functional.
Here, we provided evidence that both the above assumptions are true.
Using E. coli we demonstrated that both length variants of the PemKSa1-
Sp toxin are non-toxic. The shorter version (PemKSa1-Sp1) has likely lost
the RNase activity, which explains the lack of toxicity. The structure for
PemK toxin is not available, however the crystal structure of homo-
logous MazF toxin demonstrates that the last 20 aa form an alpha helix
which is involved in the toxin dimerization (Kamada et al., 2003;
Zorzini et al., 2016). It was demonstrated that only a dimer effectively
binds substrate RNA (Li et al., 2006). Inability to form a dimer by C-
terminally truncated PemKSa1-Sp1 would explain its lack of activity and
structural instability.
Surprisingly, the full-length version (PemKSa1-Sp2) retained RNase
activity despite the lack of toxicity. We explain this by increased sub-
strate specificity compared to S. aureus PemK-Sa1, which is significantly
toxic to E. coli and to the native host (Bukowski et al., 2013). The
average number of transcripts accessible to sequence-specific RNases
correlates inversely with the length of the target sequence. The se-
quence recognized by PemK-Sa1 (UAUU) appears every 77 bases in
random transcripts. Such sequence is thus expected at least once in
every single gene. Indeed, among 2,689 open reading frames (ORFs)
within the genome of S. aureus ED98 (carrying pemIK-Sa1 system on
pAvX plasmid) the target sequence is absent only in 56 ORFs (2%).
Penta-nucleotide sequence (UACAU) recognized by MazFSa, is expected
on average every 578 bases. Here the number of transcripts devoid of
the target sequence reaches 967 genes – 36 % of all transcripts. The
CUAUUU sequence effectively hydrolyzed by PemKSa1-Sp2 is absent in
1666 ORFs (out of 2452 ORFs found in S. pseudintermedius HKU10-03)
which renders 68 % of all genes resistant to PemKSa1-Sp2. Only 48
transcripts contain 3 or more (max. 5) target sites. These statistical
considerations may explain the lack of toxicity of PemKSa1-Sp2. How-
ever, we should bear in mind that the toxicity may as well result from a
small number of cleavages in crucial genes. It has been demonstrated
that hydrolysis of only a single essential gene transcript in E. coli by
MazF-hw toxin (targeting a seven-nucleotide sequence UUACUCA) is
enough to abolish the growth of bacteria (Yamaguchi et al., 2012).
Interestingly, despite the fact that both natural variants of PemKSa1-
Sp toxin are non-toxic and the antitoxins are significantly truncated
compared to their S. aureus homologues, the antitoxins still retain the
inhibitory activity against their cognate toxins, the significance of
which is unclear. The shortest functional antitoxin (PemISa1-Sp2) con-
sists of 30 aa, which is only one-third of the full-length prototype PemI-
Sa1 (89 aa). This is, however, consistent with prior data. Antitoxins
within type II TA systems consist of two domains. The N-terminal do-
main interacts with DNA, often with the TA system promoter. The C-
terminal domain binds the toxin, inhibiting its activity (Kamada et al.,
2003). Thus, in retrospect, it is not surprising that the truncated anti-
toxins of S. pseudintermedius retain inhibitory activity.
The plasmid-encoded TA systems clearly play a role in the main-
tenance of these mobile genetic elements by eliminating bacteria that
have lost the plasmid during the cell division process. This requires a
deleterious and irreversible mechanism. When the MGE is lost, the la-
bile antitoxin is quickly depleted while the stable toxin hinders the
growth of the daughter cells that have lost the plasmid. But, the role of
plasmid-located TA systems is not limited to stable maintenance of
MGEs, as exemplified by PemIK-Sa1 (Bukowski et al., 2013). PemIK-Sa1
and certain other plasmid-encoded systems additionally act as reg-
ulators of gene expression. Here, the toxin activation is likely reversible.
In turn, it seems that chromosomally encoded systems act by multilevel
mechanisms simultaneously affecting a large number of targets. Such
control would imply fine-tuning by co-evolution of genomes and toxin
specificities. Additionally, reversibility would be another requirement.
However, the functions of chromosomally encoded TA systems are less
well defined and the understanding of their role is the subject of an on-
going investigation.
Fig. 4. Complex formation between PemKSa1-Sp2 toxin and PemISa1-Sp2, PemISa1-Sp3 and PemISa1-Sp5 antitoxins. (A.) Size Exclusion Chromatography (SEC) of
PemKSa1-Sp2 toxin, different PemISa1-Sp antitoxin variants and mixtures. (B.) SDS-PAGE and (C.) agarose gel electrophoresis from MS2 RNA cleavage test of fractions
obtained from SEC. On SDS-PAGE gels, bands corresponding to PemKSa1-Sp2 toxin (*) and PemISa1-Sp antitoxin (**) are marked.
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Further complexity is introduced by cross-interactions and compe-
tition between homologues (paralogues) of TA system (Yang et al.,
2010; Zhu et al., 2010). Competition between plasmid-encoded TA
systems (referred to as “addiction modules”) and those located at the
chromosome (or other plasmids), where the latter provide “anti-ad-
diction” antitoxins, leads to a complicated arms-race between chro-
mosomally- and plasmid-encoded TA systems, which may result in
elimination/exclusivity of certain combinations (Goeders and Van
Melderen, 2014). Cross-reactivity of S. pseudintermedius antitoxins with
S. aureus toxin described in this study may suggest an exclusion me-
chanism based on anti-addiction, preventing stable acquisition of
homologous PemIK systems by horizontal gene transfer. This is, how-
ever, highly speculative at this moment.
Concluding, the chromosomal localization of pemIKSa1-Sp resulted
in the loss of toxicity of the PemKSa1-Sp toxin through increased se-
quence specificity. In such a case, the PemISa1-Sp antitoxin should be
released from two important functions, (i) inhibitory and (ii) the reg-
ulatory, which control expression of the whole system. Nonetheless, our
study demonstrates that even substantial N-terminal truncation of the
antitoxin does not deprive it of the inhibitory activity. This indicates
potential evolutionary pressure to maintain antitoxin functionality.
When the absence of toxicity of the toxin is taken into account, the
existence of such pressure and its relevance seem perplexing and defi-
nitely require further investigation.
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